| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |